Geoffrey Oxnard
MD
Chief Medical Officer; Former Professor of Medicine, Harvard Medical School
👥Biography 个人简介
Geoffrey Oxnard is a pioneer in applying liquid biopsy technologies to EGFR-mutant lung cancer diagnosis and treatment monitoring. His work established ctDNA-based EGFR T790M testing as a non-invasive alternative to re-biopsy, transforming clinical practice. At Foundation Medicine, he leads efforts to integrate comprehensive genomic profiling into routine oncology care. He has published extensively on plasma genotyping and longitudinal monitoring of EGFR-driven cancers.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Geoffrey Oxnard 的研究动态
Follow Geoffrey Oxnard's research updates
留下邮箱，当我们发布与 Geoffrey Oxnard（Foundation Medicine / Dana-Farber Cancer Institute）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment